Table 2.
Change in body mass index, metabolic characteristics, and adipokines before and after 6 months weight reduction surgery
| Variable | Baseline mean±SD | Follow-up mean±SD | p value |
|---|---|---|---|
| Body mass index (kg/m2) | |||
| All (n=15) | 48.81±9.46 | 44.31±8.9 | <0.001 |
| RYGB (n=9) | 49.69±10.88 | 44.95±10.55 | <0.001 |
| OS (n=6) | 47.50±7.59 | 43.39±6.64 | 0.001 |
| Fasting blood glucose (mg/dl) | |||
| All (n=15) | 140.41±41.57 | 104±43.28 | 0.001 |
| RYGB (n=9) | 132.57±36.85 | 85.77±12.10 | <0.001 |
| OS (n=6) | 152.16±48.85 | 131.33±59.30 | 0.16 |
| SBP (mmHg) | |||
| All (n=15) | 125±17.14 | 139.8±18.13 | 0.86 |
| RYGB (n=9) | 120.22±15.08 | 135.55±16.44 | 0.95 |
| OS (n=6) | 132.16±18.87 | 146.16±20.18 | 0.93 |
| Total adiponectin (mcg/ml) | |||
| All (n=15) | 26.80±15.44 | 26.28±15. 91 | 0.53 |
| RYGB (n=9) | 20.74±8.46 | 30.80±17.10 | 0.06 |
| OS (n=6) | 35.88±19.71 | 19.50±12.21 | 0.97 |
| Resistin (ng/ml) | |||
| All (n=15) | 38.6±4.0 | 61.120±9.8 | 0.19 |
| RYGB (n=9) | 39.7±3.9 | 38.717±3.4 | 0.33 |
| OS (n=6) | 37.7±4.4 | 94.724±15.8 | 0.79 |
| Leptin (ng/ml) | |||
| All (n=15) | 18.9±8.9 | 9.86±6.4 | <0.001 |
| RYGB (n=9) | 17.8±8.9 | 6.96±2.1 | 0.002 |
| OS (n=6) | 20.4±9.6 | 14.8±5.9 | 0.03 |
| Total cholesterol (mg/dl) | |||
| All (n=15) | 165.66±47.35 | 146.33±29.65 | 0.02 |
| RYGB (n=9) | 171±49.73 | 141.88±28.82 | 0.02 |
| OS (n=6) | 157.66±46.84 | 153±32.30 | 0.34 |
| LDL cholesterol (mg/dl) | |||
| All (n=15) | 96.46±43.51 | 82.46±26.61 | <0.001 |
| RYGB (n=9) | 101.66±43.40 | 82.44±21.55 | 0.07 |
| OS (n=6) | 88.66±46.54 | 82.5±35.21 | 0.28 |
| HDL cholesterol (mg/dl) | |||
| All (n=14) | 37.6±6.45 | 39.13±4.29 | 0.14 |
| RYGB (n=8) | 36.22±7.25 | 39.77±4.91 | 0.03 |
| OS (n=6) | 39.66±4.88 | 38.16±3.31 | 0.23 |
| Triglycerides (mg/dl) | |||
| All (n=15) | 152.93±92.79 | 117.26±63.79 | 0.06 |
| RYGB (n=9) | 159.33±102.34 | 87.33±28.54 | 0.02 |
| OS (n=6) | 145.83±84.95 | 162.16±77.83 | 0.72 |
| HbA1C (%) | |||
| All (n=15) | 7.1±1.0 | 6.0±0.7 | 0.004 |
| RYGB (n=9) | 6.8±0.9 | 5.6±0.4 | 0.005 |
| OS (n=6) | 7.5±1.0 | 6.5±0.8 | 0.02 |
| TNF-alpha | |||
| All (n=15) | 1.84±1.07 | 1.76±3.11 | 0.45 |
| Roux-en-Y (n=9) | 1.46±0.86 | 1.25±1.41 | 0.29 |
| OS/Banding (n=6) |
1.50±4.77 | 4.13±4.77 | 0.93 |
| Serum creatinine (mg/dl) | |||
| All (n=15) | 0.78±0.21 | 0.64±0.10 | <0.001 |
| RYGB (n=9) | 0.75±0.13 | 0.65±0.07 | 0.007 |
| OS (n=6) | 0.81±0.30 | 0.62±0.13 | 0.02 |
| Serum cystatin (ng/ml) | |||
| All (n=14) | 1,322.76±339.22 | 1,246.12±238.49 | 0.18 |
| RYGB (n=8) | 1,426.10±389.29 | 1,360.72±209.03 | 0.32 |
| OS (n=6) | 1,184.96±192.91 | 1,093.33±194.12 | 0.17 |
RYGB Roux-en-Y gastric bypass, OS other types of bariatric surgery